This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Apr 3:20:793-794.

doi: 10.2147/NDT.S468941. eCollection 2024.

4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke via Inhibiting MAPK Pathway [Letter]

Agriani Dini Pasiana^#¹, Hasta Handayani Idrus^#¹

Affiliations

Affiliation

¹ Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Center, Bogor, West Java, Indonesia.

^# Contributed equally.

PMID: 38586308
PMCID: PMC10999189
DOI: 10.2147/NDT.S468941

4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke via Inhibiting MAPK Pathway [Letter]

Agriani Dini Pasiana et al. Neuropsychiatr Dis Treat. 2024.

. 2024 Apr 3:20:793-794.

doi: 10.2147/NDT.S468941. eCollection 2024.

Authors

Agriani Dini Pasiana^#¹, Hasta Handayani Idrus^#¹

Affiliation

¹ Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Center, Bogor, West Java, Indonesia.

^# Contributed equally.

PMID: 38586308
PMCID: PMC10999189
DOI: 10.2147/NDT.S468941

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this communication.

Similar articles

4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke via Inhibiting MAPK Pathway.
Wang L, Qu Z, Sun Q, Mao Z, Si P, Wang W. Wang L, et al. Neuropsychiatr Dis Treat. 2024 Mar 7;20:523-533. doi: 10.2147/NDT.S444760. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38469210 Free PMC article.
Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway.
Zhang L, Zhou T, Ji Q, He L, Lan Y, Ding L, Li L, Wang Z. Zhang L, et al. Mol Biol Rep. 2023 Mar;50(3):2545-2557. doi: 10.1007/s11033-022-08238-8. Epub 2023 Jan 8. Mol Biol Rep. 2023. PMID: 36611117
miR-145 protects the function of neuronal stem cells through targeting MAPK pathway in the treatment of cerebral ischemic stroke rat.
Xue WS, Wang N, Wang NY, Ying YF, Xu GH. Xue WS, et al. Brain Res Bull. 2019 Jan;144:28-38. doi: 10.1016/j.brainresbull.2018.08.023. Epub 2018 Sep 1. Brain Res Bull. 2019. PMID: 30179678
MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target.
Gugliandolo A, Silvestro S, Sindona C, Bramanti P, Mazzon E. Gugliandolo A, et al. Medicina (Kaunas). 2021 Oct 1;57(10):1053. doi: 10.3390/medicina57101053. Medicina (Kaunas). 2021. PMID: 34684090 Free PMC article. Review.
MAPK: A Key Player in the Development and Progression of Stroke.
Zheng Y, Han Z, Zhao H, Luo Y. Zheng Y, et al. CNS Neurol Disord Drug Targets. 2020;19(4):248-256. doi: 10.2174/1871527319666200613223018. CNS Neurol Disord Drug Targets. 2020. PMID: 32533818 Review.

See all similar articles

References

1. Wang L, Qu Z, Sun Q, Mao Z, Si P, Wang W. 4-hydroxysesamin, a modified natural compound, attenuates neuronal apoptosis after ischemic stroke via inhibiting MAPK pathway. Neuropsy Dis Treat. 2024;20:523–533 doi:10.2147/NDT.S444760. - DOI - PMC - PubMed
1. Dalibalta S, Majdalawieh AF, Manjikian H. Health benefits of sesamin on cardiovascular disease and its associated risk factors. Saudi Pharm J. 2020;28(10):1276–1289. doi:10.1016/j.jsps.2020.08.018 - DOI - PMC - PubMed
1. Rosalina R, Weerapreeyakul N. An insight into sesamolin: physicochemical properties, pharmacological activities, and future research prospects. Molecules. 2021;26(19):5849. doi:10.3390/molecules26195849 - DOI - PMC - PubMed
1. Holloway PM, Gavins FN. Modeling ischemic stroke in vitro: status quo and future perspectives. Stroke. 2016;47(2):561–569. doi:10.1161/STROKEAHA.115.011932 - DOI - PMC - PubMed
1. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review). Int J Mol Med. 2022;49(2):15. doi:10.3892/ijmm.2021.5070 - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources